Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 260

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Diagnostic odyssey in severe neurodevelopmental disorders: toward clinical whole‐exome sequencing as a first‐line diagnostic test

Thevenon, J., Duffourd, Y., Masurel‐Paulet, A., Lefebvre, M., Feillet, F., El Chehadeh‐Djebbar, S., St‐Onge, J., Steinmetz, A., Huet, F., Chouchane, M., Darmency‐Stamboul, V., Callier, P., Thauvin‐Robinet, C., Faivre, L., Rivière, J.B.·2016·Clinical Genetics

Abstract

The current standard of care for diagnosis of severe intellectual disability (ID) and epileptic encephalopathy (EE) results in a diagnostic yield of ∼50%. Affected individuals nonetheless undergo multiple clinical evaluations and low‐yield laboratory tests often referred to as a ‘diagnostic odyssey’. This study was aimed at assessing the utility of clinical whole‐exome sequencing (WES) in individuals with undiagnosed and severe forms of ID and EE, and the feasibility of its implementation in routine practice by a small regional genetic center. We performed WES in a cohort of 43 unrelated individuals with undiagnosed ID and/or EE. All individuals had undergone multiple clinical evaluations and diagnostic tests over the years, with no definitive diagnosis. Sequencing data analysis and interpretation were carried out at the local molecular genetics laboratory. The diagnostic rate of WES reached 32.5% (14 out of 43 individuals). Genetic diagnosis had a direct impact on clinical management in four families, including a prenatal diagnostic test in one family. Our data emphasize the clinical utility and feasibility of WES in individuals with undiagnosed forms of ID and EE and highlight the necessity of close collaborations between ordering physicians, molecular geneticists, bioinformaticians and researchers for accurate data interpretation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/cge.12732

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 260

Metadata

Authors
Thevenon, J., Duffourd, Y., Masurel‐Paulet, A., Lefebvre, M., Feillet, F., El Chehadeh‐Djebbar, S., St‐Onge, J., Steinmetz, A., Huet, F., Chouchane, M., Darmency‐Stamboul, V., Callier, P., Thauvin‐Robinet, C., Faivre, L., & Rivière, J. B.
Venue
Clinical Genetics
Publisher
Wiley
Published
2016-04-26
Volume
89
Issue
6
Pages
700-707
ISSN
  • 0009-9163 (ISSN-L)
  • 1399-0004
OpenAlex
W2292578091
Cited by
260
References
8
FWCI
22.50
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Diagnostic odyssey in severe neurodevelopmental disorders: toward clinical whole‐exome sequencing as a first‐line diagnostic test. https://app.cochat.ai/papers/10.1111/cge.12732
The paper
Thevenon, J., Duffourd, Y., Masurel‐Paulet, A., Lefebvre, M., Feillet, F., El Chehadeh‐Djebbar, S., St‐Onge, J., Steinmetz, A., Huet, F., Chouchane, M., Darmency‐Stamboul, V., Callier, P., Thauvin‐Robinet, C., Faivre, L., & Rivière, J. B. (2016). Diagnostic odyssey in severe neurodevelopmental disorders: toward clinical whole‐exome sequencing as a first‐line diagnostic test. Clinical Genetics. https://doi.org/10.1111/cge.12732

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.